Ruping Shao

Liaoning Provincial People's Hospital — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index1.9kcitations67works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Research and Treatments(15), Virus-based gene therapy research(13), Lung Cancer Treatments and Mutations(7), RNA Interference and Gene Delivery(7), Cancer-related molecular mechanisms research(6)

Publications67 total

Superiority of a combined antithrombin and activated protein C model for predicting coagulopathy and mortality in pneumonia-related sepsis: A prospective cohort study
Thrombosis Research·2025Open Access
The effectiveness of symptom-oriented mind mapping combined with problem-based learning in critical care clerkships: a randomized controlled trial
Frontiers in Public Health·2025· 1 citedOpen Access
CPT2 inhibition enhances selective autophagy and proliferation in colorectal cancer via GPAT4-dependent glycerophospholipid biosynthesis
Communications Biology·2025· 3 citedOpen Access
Xijiao Dihuang Decoction for Sepsis-Induced Acute Lung Injury: Network Pharmacology and Molecular Dynamics Insights
Journal of Inflammation Research·2025· 1 citedOpen Access
Lightweighting method of the BIM model based on geometric features
2024
Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib
Communications Biology·2023Open Access
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib
Communications Biology·2023· 11 citedOpen Access
Supplementary Figure Legends from An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses
2023Open Access
Supplementary Figure Legends from An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses
2023Open Access
Supplementary Figures from An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses
2023Open Access
Supplementary Figures from An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses
2023Open Access
Data from An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses
2023Open Access
Data from An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses
2023Open Access
Research on building energy consumption prediction based on multi-level attention mechanism
2022· 1 cited
Abstract 5354: 3-phosphoinositide-dependent kinase-1 (PDK1, PDPK1) is a driver of osimertinib acquired resistance in EGFR mutant NSCLC
Cancer Research·2022
TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model
Communications Biology·2022· 24 citedOpen Access
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib
2021· 1 citedOpen Access
Abstract 76: TUSC2 immunogene therapy enhances efficacy of chemo-immune combination therapy and induces robust antitumor immunity in KRAS-LKB1 mutant NSCLC in humanized mice
Cancer Research·2021
Abstract 1105: Overcoming resistance to osimertinib by TUSC2 gene therapy in EGFR mutant NSCLC
Cancer Research·2021
Abstract 4454: TUSC2 immunogene therapy enhances efficacy of immunotherapy and targeted drugs in human non-small cell lung cancer (NSCLC) in humanized mouse models
Cancer Research·2020
page 1 of 4Next →

Frequent Co-authors

Mien‐Chie Hung(16), Jack A. Roth(15), Mourad Majidi(11), Bingliang Fang(10), Ismail M. Meraz(8), Stephen G. Swisher(7), Apar Pataer(7), Min Jin Ha(7), Elizabeth J. Shpall(7), Ignacio I. Wistuba(6), Weiya Xia(5), Lin Ji(5), Arlene M. Correa(5), Feng Meng(5), Chun Li(4), Bill Spohn(4), Carmen Behrens(4), Jeffrey S. Morris(4), Yi Ding(3), Juri G. Gelovani(3)